Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
2021-07-08 $0.0500 $0.0653 $0.0500 $0.0650 65 966
2021-07-07 $0.0502 $0.0654 $0.0500 $0.0654 3 102
2021-07-06 $0.0652 $0.0655 $0.0501 $0.0650 135 500
2021-07-02 $0.0650 $0.0650 $0.0650 $0.0650 124
2021-07-01 $0.0650 $0.0650 $0.0579 $0.0650 16 313
2021-06-30 $0.0501 $0.0653 $0.0501 $0.0653 120 274
2021-06-29 $0.0653 $0.0654 $0.0578 $0.0654 7 985
2021-06-28 $0.0601 $0.0654 $0.0600 $0.0654 3 270
2021-06-25 $0.0642 $0.0683 $0.0601 $0.0680 107 914
2021-06-24 $0.0600 $0.0683 $0.0600 $0.0683 6 466
2021-06-23 $0.0600 $0.0684 $0.0600 $0.0684 17 459
2021-06-22 $0.0505 $0.0695 $0.0505 $0.0680 40 801
2021-06-21 $0.0601 $0.0709 $0.0600 $0.0695 24 388
2021-06-18 $0.0709 $0.0709 $0.0600 $0.0709 28 435
2021-06-17 $0.0710 $0.0710 $0.0600 $0.0680 169 737
2021-06-16 $0.0576 $0.0760 $0.0510 $0.0680 169 737
2021-06-15 $0.0640 $0.0640 $0.0500 $0.0500 151 906
2021-06-14 $0.0795 $0.0795 $0.0645 $0.0755 69 740
2021-06-11 $0.0795 $0.0795 $0.0645 $0.0795 61 028
2021-06-10 $0.0800 $0.0850 $0.0635 $0.0794 61 894
2021-06-09 $0.0701 $0.0800 $0.0701 $0.0790 1 906
2021-06-08 $0.0800 $0.0801 $0.0688 $0.0795 122 519
2021-06-07 $0.0638 $0.0800 $0.0638 $0.0800 7 605
2021-06-04 $0.0700 $0.0795 $0.0700 $0.0795 5 742
2021-06-03 $0.0695 $0.0800 $0.0695 $0.0799 1 581
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT